Epidemiology of diarrhoeal disease

implications for control by vaccines

Research output: Contribution to journalArticle

Abstract

Vaccines present perhaps the most attractive solution to the worldwide problem of diarrhoeal disease. Epidemiological evidence has important implications for the development and use of such vaccines, and results of studies on diarrhoeal diseases in developing and developed countries, in particular among children, and travellers' diarrhoea are reviewed. The virulence and pathogenicity of various enteropathogens are discussed, and the extent to which immunity may be acquired. It is concluded that the development of appropriate vaccines may be a complex task.

Original languageEnglish (US)
Pages (from-to)100-106
Number of pages7
JournalVaccine
Volume11
Issue number2
DOIs
StatePublished - 1993

Fingerprint

epidemiology
disease control
Epidemiology
Vaccines
vaccines
Virulence
enteropathogens
Developed Countries
developed countries
Developing Countries
developing countries
Diarrhea
Immunity
diarrhea
virulence
pathogenicity
immunity

Keywords

  • Diarrhoea
  • enteropathogens
  • epidemiology
  • immunity
  • infantile virulence
  • pathogenicity

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Epidemiology of diarrhoeal disease : implications for control by vaccines. / Black, Robert E.

In: Vaccine, Vol. 11, No. 2, 1993, p. 100-106.

Research output: Contribution to journalArticle

@article{aacb53b269084772bd0c80c40b0e5e3f,
title = "Epidemiology of diarrhoeal disease: implications for control by vaccines",
abstract = "Vaccines present perhaps the most attractive solution to the worldwide problem of diarrhoeal disease. Epidemiological evidence has important implications for the development and use of such vaccines, and results of studies on diarrhoeal diseases in developing and developed countries, in particular among children, and travellers' diarrhoea are reviewed. The virulence and pathogenicity of various enteropathogens are discussed, and the extent to which immunity may be acquired. It is concluded that the development of appropriate vaccines may be a complex task.",
keywords = "Diarrhoea, enteropathogens, epidemiology, immunity, infantile virulence, pathogenicity",
author = "Black, {Robert E}",
year = "1993",
doi = "10.1016/0264-410X(93)90002-F",
language = "English (US)",
volume = "11",
pages = "100--106",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Epidemiology of diarrhoeal disease

T2 - implications for control by vaccines

AU - Black, Robert E

PY - 1993

Y1 - 1993

N2 - Vaccines present perhaps the most attractive solution to the worldwide problem of diarrhoeal disease. Epidemiological evidence has important implications for the development and use of such vaccines, and results of studies on diarrhoeal diseases in developing and developed countries, in particular among children, and travellers' diarrhoea are reviewed. The virulence and pathogenicity of various enteropathogens are discussed, and the extent to which immunity may be acquired. It is concluded that the development of appropriate vaccines may be a complex task.

AB - Vaccines present perhaps the most attractive solution to the worldwide problem of diarrhoeal disease. Epidemiological evidence has important implications for the development and use of such vaccines, and results of studies on diarrhoeal diseases in developing and developed countries, in particular among children, and travellers' diarrhoea are reviewed. The virulence and pathogenicity of various enteropathogens are discussed, and the extent to which immunity may be acquired. It is concluded that the development of appropriate vaccines may be a complex task.

KW - Diarrhoea

KW - enteropathogens

KW - epidemiology

KW - immunity

KW - infantile virulence

KW - pathogenicity

UR - http://www.scopus.com/inward/record.url?scp=0027526003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027526003&partnerID=8YFLogxK

U2 - 10.1016/0264-410X(93)90002-F

DO - 10.1016/0264-410X(93)90002-F

M3 - Article

VL - 11

SP - 100

EP - 106

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 2

ER -